1Ganguli R, Brat JS, Chengappa KR, et al. Mitogen-stimualted interleukin-2 production in never-medicatied, first-episode schizophrenic patient. The influence of age at onset and negative symptoms. Arch Gen Psychiatry, 1995,52(8) :668.
2Maes M, Melter HY, Bosmans E, et al.Immune-inflammatory markexsin schizophrenia,Comparison to normal and effects of clozapine. Acta Psychiatr Scand,1994,89(9) :346.
3Maes M,Bosmana E,Raijan R. Lower CC16,a natural anti-inflammatory protein, and increased plasma interleukin Ⅰ receptor antagonist in schizophrenia,effects of antipsychotic drugs, Schizohr Res, 1996,21(1) :39.
8Rapaport Mh, Lohr Jb. Serum-soluble interleukin-2 receptors in neurolptic-native schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand, 1994,90(5):311.
8Kim YK,Lee MS,Suh KY.Dcereased interleukin- production in Korean schizophrenia patients. Biol Psychiatry 1998;43(9): 701-704
9Arolt V, Rothermunth M,Wandinger KEet al. Dcereased in vitro production of interferon- gamma and interleukin- 2 in whole blood of par tients with schizophrenia during treatment. Mol Psychiatry 2000;5(2): 150-158
10Lapchak PA.A role for interleukin-2 in the regulation of striatal dopaminergic function.Neuroreport 1992;3(2): 165-168
